Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma
Chun, R.; Garrett, L.D.; Vail, D.M.
Journal of Veterinary Internal Medicine 14(2): 120-124
2000
ISSN/ISBN: 0891-6640
PMID: 10772481
DOI: 10.1111/j.1939-1676.2000.tb02224.x
Accession: 003437661
The purpose of this study was to evaluate the efficacy and toxicity of an intensified dose protocol with no maintenance phase for the treatment of canine lymphoma. 49 dogs all weighing more than 15 kg were entered. Dogs were staged and treated with a modified version of the University of Wisconsin (UW)-Madison protocol for lymphoma.
PDF emailed within 0-6 h: $19.90
Related References
Garrett, L.D.; Thamm, D.H.; Chun, R.; Dudley, R.; Vail, D.M. 2002: Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma Journal of Veterinary Internal Medicine 16(6): 704-709Siedlecki, C.T.; Kass, P.H.; Jakubiak, M.J.; Dank, G.; Lyons, J.; Kent, M.S. 2006: Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma Canadian Veterinary Journal 47(1): 52-59
Simon, D.; Nolte, I.; Eberle, N.; Abbrederis, N.; Killich, M.; Hirschberger, J. 2006: Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol Journal of Veterinary Internal Medicine 20(4): 948-954
Piek, C.J.; Rutteman, G.R.; Teske, E. 1999: Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma Veterinary Quarterly 21(2): 44-49
Weide, R.; Heymanns, J.; Koeppler, H. 2003: Rituximab maintenance therapy achieves a long term remission in a patient with aggressive lymphoma who relapsed after high dose chemotherapy Blood 102(11): 303b
Merryman, R.W.; Redd, R.; Jeter, E.; Wong, J.L.; McHugh, K.; Reynolds, C.; Nazzaro, M.; Varden, A.; Brown, J.R.; Crombie, J.L.; Davids, M.S.; Fisher, D.C.; Jacobsen, E.; Jacobson, C.A.; Kim, A.I.; LaCasce, A.S.; Ng, S.Y.; Odejide, O.O.; Parry, E.M.; Dahi, P.B.; Nieto, Y.; Joyce, R.M.; Chen, Y.-B.; Herrera, A.F.; Armand, P.; Ritz, J. 2022: Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma Transplantation and Cellular Therapy 28(1): 32.E1-32.E10
Mishima, K.; Miyake, Y. 2017: P15.05 High-dose methotrexate based immuno-chemotherapy with maintenance chemotherapy with High-dose methotrexate and deferred radiotherapy for elderly primary Cns lymphoma patients Neuro-Oncology 19(Suppl_3): iii 108-iii 109
Huenerlituerkoglu, A.; Kobbe, G.; Bauser, U.; Schneider, P.; Meckenstock, G.; Niederste Hollenberg, A.; Aul, C.; Heyll, A. 1998: High-dose idarubicin added to CBV as an intensified high-dose-chemotherapy protocol for patients with primary refractory or relapsed malignant lymphoma Annals of Hematology 77(Suppl 2): S192
Zenker, I.; Meichner, K.; Steinle, K.; Kessler, M.; Hirschberger, J. 2010: Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs Veterinary Record 167(19): 744-748
Sorenmo, K.; Overley, B.; Krick, E.; Ferrara, T.; LaBlanc, A.; Shofer, F. 2010: Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases Veterinary and Comparative Oncology 8(3): 196-208
Myers, N.C.; Moore, A.S.; Rand, W.M.; Gliatto, J.; Cotter, S.M. 1997: Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma Journal of Veterinary Internal Medicine 11(6): 333-339
Sweetenham, J.W.; Santini, G.; Qian, W.; Guelfi, M.; Schmitz, N.; Simnett, S.; Nagler, A.; Holte, H.; Kvaloy, S.; Bruzzi, P.; Goldstone, A.H. 2001: High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(11): 2927-2936
Daters,A.T.; Mauldin,G.E.; Mauldin,G.N.; Brodsky,E.M.; Post,G.S. 2010: Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance for the treatment of canine lymphoma Veterinary And Comparative Oncology: 1, 11-22
Daters, A.T.; Mauldin, G.E.; Mauldin, G.N.; Brodsky, E.M.; Post, G.S. 2010: Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma Veterinary and Comparative Oncology 8(1): 11-22
Gallardo, J.; Greening, L.; Siegel, R.; Tabbara, I. 1997: A novel high-dose chemotherapy protocol with autologous stem cell transplant for malignant lymphoma Blood 90(10 Suppl 1 Pt 2): 402B-403B
Buckstein, R.J.; Mangel, J.; Imrie, K.R.; Spaner, D.; Boudreau, A.; Crump, M.; Pao, J.S.; Foden, C.; Berinstein, N. 2002: Immunoglobulin Recovery Following High Dose Therapy and Post-ASCT Rituximab for Relapsed Follicular Lymphoma and Newly Diagnosed Mantle Cell Lymphoma Compared to Standard Dose Chemotherapy +/- Rituximab Blood 100(11): Abstract No. 5502
Schaaf, M.; Reiser, M.; Borchmann, P.; Engert, A.; Skoetz, N. 2012: High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults Cochrane Database of Systematic Reviews 1: Cd007678
Blay, J.Y.; Bouhour, D.; Carrie, C.; Bouffet, E.; Brunat-Mentigny, M.; Philip, T.; Biron, P. 1995: The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression Blood 86(8): 2922-2929
Harada, M.; Imajo, K.; Shinagawa, K.; Gondo, H.; Kawano, F.; Ogawa, M.; Takaku, F. 2003: Randomized phase II study of maintenance chemotherapy versus high-dose chemotherapy with autologous peripheral blood stem cell transplantation as postremission therapy of AML Experimental Hematology (New York) 31(7 Suppl 1): 107
Veluvolu, S.; Pellin, M.; Vos, N. 2021: Evaluation of neutrophilia as a prognostic factor in dogs with multicentric lymphoma treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone-based chemotherapy protocol Journal of the American Veterinary Medical Association 259(5): 494-502